Coronavirus-related research and services at EMBL

The molecular life sciences have a central role in delivering new treatments or vaccines against Sars-CoV-2. EMBL has re-purposed existing facilities to provide a range of direct research and support services, including in partnership with institutes in Member States.

This document provides a summary of EMBL coronavirus-related research and service activity as at 20 April 2020, and will be updated as additional projects receive necessary safety and scientific approvals.

For more information, see link below

EMBL Covid19 activities

Featured articles